CCI Photonics boosted by £100,000 support
A life sciences firm has received £100,000 backing.
CCI Photonics has been supported by LYVA Labs to develop a urinary tract infection test.
Bosses say the apparatus will carry out a 15-minute test before identifying the correct antibiotics for treatment.
They add current methods for testing bacteria causing urinary tract infections can take up to 72 hours.
Dr Carlos Meza, CCI Photonics chief executive, said: “LYVA Labs' investment will help speed up the process of bringing our device to market, strengthen our quality management system as we prepare for regulatory approval, and develop our route-to-market strategy.”
CCI Photonics recently moved to Sci-Tech Daresbury, and has partnered with the Liverpool School of Tropical Medicine to further validate its technology.
It is taking part in the LYVA Labs’ incubator programme.
Akshay Bhatnagar, LYVA Labs’ head of investments, added: “We are excited to support Carlos and the team to develop this game-changing technology with the potential to help urinary tract infection sufferers all over the world and combat the scourge of antimicrobial resistance.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?
What new NPPF rules mean for landowners
The hidden cost squeezing Britain's economy
Teesside deserves more than cashback devolution
Construction must be built on commercial discipline
Devolution needs financial firepower to drive growth
The value of creating a stronger careers route